Literature DB >> 4088315

Second cancer following cancer of the breast in Connecticut, 1935-82.

E B Harvey, L A Brinton.   

Abstract

Among 41,109 women diagnosed with breast cancer between 1935 and 1982 in Connecticut, 3,984 developed a second cancer, whereas 2,426 were expected [relative risk (RR) = 1.64; 95% CI = 1.6-1.7]. This increased risk persisted for 30 years and was highest in women under 55 years of age at the time of breast cancer diagnosis. Second primary breast cancers (RR = 3.0) accounted for almost one-half of all new neoplasms. However, if subsequent breast cancers were excluded, the risk for all other second cancers was only 1.15 (95% CI = 1.10-1.20), and no excess risk was seen among women over age 55 at initial breast cancer. Significant risks were found for cancers of the ovary (RR = 1.7) and uterine corpus (RR = 1.4), possibly linked with shared reproductive factors such as nulliparity or late age at menopause. Malignant melanoma (RR = 1.5), thyroid cancer (RR = 1.6), and colon cancer (RR = 1.2) were also significantly elevated; possible shared risk factors remain to be elucidated. Significant deficits of multiple myeloma and chronic lymphocytic leukemia were noted. Women who received initial radiotherapy compared with those who did not were at slightly higher risk of developing a second cancer, most notably acute nonlymphocytic leukemia, non-Hodgkin's lymphoma, and cancers of the esophagus, kidney, and connective tissue, although the nature of the associations was not always clear. Some of the soft tissue sarcomas were lymphangiosarcomas of the arm, a consequence of the lymphedema that may complicate radical mastectomy (Stewart-Treves syndrome). Women treated with radiation were at higher risk of developing a second breast neoplasm (RR = 3.9) than nonirradiated women (RR = 2.8). Further investigation should focus on the mechanisms underlying the relationships between breast, genital tract, and colon cancers, and on the effects of treatment modalities on the risk of subsequent neoplasms.

Entities:  

Mesh:

Year:  1985        PMID: 4088315

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  61 in total

Review 1.  Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.

Authors:  Issa J Dahabreh; Thomas A Trikalinos; Jessica K Paulus
Journal:  Lung Cancer       Date:  2011-12-09       Impact factor: 5.705

2.  Age at diagnosis and multiple primary cancers of the breast and ovary.

Authors:  P J Suris-Swartz; J M Schildkraut; M F Vine; I Hertz-Picciotto
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.

Authors:  Bernard Friedenson
Journal:  MedGenMed       Date:  2005-06-29

4.  Risk of asynchronous contralateral breast cancer: multiple approaches for a complex issue.

Authors:  Tomi F Akinyemiju
Journal:  Gland Surg       Date:  2013-05

Review 5.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

Review 6.  Second primary breast cancer.

Authors:  O Eremin
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

7.  Risk of colorectal adenomas in women with prior breast cancer.

Authors:  Ashish Shukla; Sandhya Shukla; Ayodele Osowo; Terry Mashtare; Manoop S Bhutani; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

8.  Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers.

Authors:  G C Kabat
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

9.  In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer.

Authors:  E Robinson; D Rubin; T Mekori; R Segal; S Pollack
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

10.  Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Authors:  C Rubino; R Arriagada; S Delaloge; M G Lê
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.